R. Sorace

发表

Long‐term outcomes after treatment with external beam radiation therapy and palladium 103 for patients with higher risk prostate carcinoma

K. Wallner, L. True, M. Dattoli, 2003, Cancer.

Approach of Locally Advanced Nonmetastatic Breast Cancer Neoadjuvant Chemotherapy in the Combined Modality

S. Steinberg, S. Swain, M. Lippman, 2006 .

The management of nonmetastatic locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery

M. Lippman, A. Lichter, D. Danforth, 1985, World Journal of Surgery.

Treatment of locally advanced breast cancer using primary induction chemotherapy with hormonal synchronization followed by radiation therapy with or without debulking surgery.

M. Lippman, A. Lichter, M. Wesley, 1986, NCI monographs : a publication of the National Cancer Institute.

Treatment of stage IIIA/B locally advanced breast cancer (LABC) with induction chemotherapy (CT) and hormonal synchronization (HS) followed by radiation therapy (RT) with or without mastectomy

S. Swain, M. Lippman, D. Danforth, 1986 .

Long-term follow-up of testicular function following radiation therapy for early-stage Hodgkin's disease.

S. Steinberg, B. Fraass, T. Kinsella, 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer.

S. Steinberg, S. Swain, M. Lippman, 1987, Cancer research.

Prognostic role of serum prostatic acid phosphatase for 103Pd-based radiation for prostatic carcinoma.

K. Wallner, M. Binder, L. True, 1999, International journal of radiation oncology, biology, physics.

Prostatic acid phosphatase adversely affects cause-specific survival in patients with intermediate to high-risk prostate cancer treated with brachytherapy.

K. Wallner, L. True, A. Taira, 2008, Urology.

Long-Term Outcomes for Patients with Prostate Cancer Having Intermediate and High-Risk Disease, Treated with Combination External Beam Irradiation and Brachytherapy

K. Wallner, D. Bostwick, L. True, 2010, Journal of oncology.

Long‐term outcomes after treatment with brachytherapy and supplemental conformal radiation for prostate cancer patients having intermediate and high‐risk features

K. Wallner, L. True, M. Dattoli, 2007, Cancer.

1011 Palladium-103 brachytherapy for clinical prostate carcinomas

K. Wallner, M. Dattoli, J. Cash, 1997 .

103Pd brachytherapy and external beam irradiation for clinically localized, high-risk prostatic carcinoma.

K. Wallner, M. Binder, M. Dattoli, 1996, International journal of radiation oncology, biology, physics.

Long-term prostate cancer control using palladium-103 brachytherapy and external beam radiotherapy in patients with a high likelihood of extracapsular cancer extension.

K. Wallner, L. True, M. Dattoli, 2007, Urology.